第一三共の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/02/13 | 1,592 | 1,603 | 1,570 | 1,582 | -9 | -0.6% | 2,071,700 |
2013/02/12 | 1,567 | 1,603 | 1,566 | 1,591 | +41 | +2.6% | 3,065,500 |
2013/02/08 | 1,534 | 1,557 | 1,533 | 1,550 | -9 | -0.6% | 3,069,800 |
2013/02/07 | 1,558 | 1,564 | 1,547 | 1,559 | -3 | -0.2% | 2,431,600 |
2013/02/06 | 1,540 | 1,564 | 1,536 | 1,562 | +31 | +2% | 3,783,400 |
2013/02/05 | 1,535 | 1,545 | 1,529 | 1,531 | -12 | -0.8% | 2,600,600 |
2013/02/04 | 1,544 | 1,549 | 1,539 | 1,543 | +10 | +0.7% | 2,049,400 |
2013/02/01 | 1,538 | 1,546 | 1,530 | 1,533 | -15 | -1% | 2,039,800 |
2013/01/31 | 1,531 | 1,548 | 1,521 | 1,548 | +14 | +0.9% | 3,765,400 |
2013/01/30 | 1,533 | 1,534 | 1,521 | 1,534 | +16 | +1.1% | 2,476,300 |
2013/01/29 | 1,506 | 1,524 | 1,503 | 1,518 | +18 | +1.2% | 2,465,400 |
2013/01/28 | 1,527 | 1,535 | 1,498 | 1,500 | -8 | -0.5% | 2,487,000 |
2013/01/25 | 1,486 | 1,508 | 1,480 | 1,508 | +41 | +2.8% | 3,113,400 |
2013/01/24 | 1,427 | 1,467 | 1,426 | 1,467 | +40 | +2.8% | 2,687,900 |
2013/01/23 | 1,460 | 1,460 | 1,424 | 1,427 | -40 | -2.7% | 3,244,600 |
2013/01/22 | 1,484 | 1,484 | 1,448 | 1,467 | -12 | -0.8% | 2,946,400 |
2013/01/21 | 1,496 | 1,499 | 1,479 | 1,479 | -5 | -0.3% | 2,302,800 |
2013/01/18 | 1,485 | 1,487 | 1,476 | 1,484 | +20 | +1.4% | 3,202,300 |
2013/01/17 | 1,453 | 1,472 | 1,445 | 1,464 | +12 | +0.8% | 3,597,800 |
2013/01/16 | 1,456 | 1,469 | 1,446 | 1,452 | -2 | -0.1% | 3,726,300 |
2013/01/15 | 1,440 | 1,454 | 1,436 | 1,454 | +31 | +2.2% | 3,248,300 |
2013/01/11 | 1,395 | 1,426 | 1,395 | 1,423 | +31 | +2.2% | 3,284,200 |
2013/01/10 | 1,379 | 1,394 | 1,378 | 1,392 | +17 | +1.2% | 2,580,400 |
2013/01/09 | 1,366 | 1,382 | 1,359 | 1,375 | +13 | +1% | 2,429,100 |
2013/01/08 | 1,371 | 1,371 | 1,358 | 1,362 | -7 | -0.5% | 2,205,800 |
2013/01/07 | 1,378 | 1,379 | 1,365 | 1,369 | +8 | +0.6% | 2,229,000 |
2013/01/04 | 1,349 | 1,362 | 1,344 | 1,361 | +39 | +3% | 2,996,200 |
2012/12/28 | 1,325 | 1,328 | 1,316 | 1,322 | +1 | +0.1% | 1,772,500 |
2012/12/27 | 1,320 | 1,332 | 1,316 | 1,321 | +1 | +0.1% | 2,541,400 |
2012/12/26 | 1,315 | 1,320 | 1,311 | 1,320 | +8 | +0.6% | 1,383,400 |
2012/12/25 | 1,320 | 1,321 | 1,307 | 1,312 | +3 | +0.2% | 1,593,500 |
2012/12/21 | 1,321 | 1,321 | 1,306 | 1,309 | -1 | -0.1% | 2,231,000 |
2012/12/20 | 1,320 | 1,322 | 1,307 | 1,310 | -12 | -0.9% | 3,753,700 |
2012/12/19 | 1,310 | 1,322 | 1,304 | 1,322 | +22 | +1.7% | 2,919,800 |
2012/12/18 | 1,297 | 1,303 | 1,295 | 1,300 | +2 | +0.2% | 2,192,000 |
2012/12/17 | 1,303 | 1,314 | 1,293 | 1,298 | +2 | +0.2% | 2,475,200 |
2012/12/14 | 1,288 | 1,303 | 1,285 | 1,296 | ±0 | ±0% | 4,599,000 |
2012/12/13 | 1,300 | 1,302 | 1,291 | 1,296 | +1 | +0.1% | 1,530,700 |
2012/12/12 | 1,300 | 1,303 | 1,294 | 1,295 | ±0 | ±0% | 1,426,400 |
2012/12/11 | 1,287 | 1,295 | 1,287 | 1,295 | +7 | +0.5% | 1,178,800 |
2012/12/10 | 1,289 | 1,291 | 1,284 | 1,288 | ±0 | ±0% | 1,260,700 |
2012/12/07 | 1,282 | 1,289 | 1,282 | 1,288 | +7 | +0.5% | 1,276,600 |
2012/12/06 | 1,283 | 1,290 | 1,280 | 1,281 | +2 | +0.2% | 1,851,700 |
2012/12/05 | 1,275 | 1,285 | 1,273 | 1,279 | -2 | -0.2% | 1,989,700 |
2012/12/04 | 1,276 | 1,284 | 1,272 | 1,281 | +8 | +0.6% | 1,810,800 |
2012/12/03 | 1,278 | 1,280 | 1,266 | 1,273 | +1 | +0.1% | 1,345,200 |
2012/11/30 | 1,267 | 1,285 | 1,262 | 1,272 | +10 | +0.8% | 2,579,100 |
2012/11/29 | 1,261 | 1,266 | 1,256 | 1,262 | +7 | +0.6% | 1,212,200 |
2012/11/28 | 1,260 | 1,270 | 1,254 | 1,255 | -11 | -0.9% | 1,620,400 |
2012/11/27 | 1,263 | 1,272 | 1,260 | 1,266 | +12 | +1% | 1,863,400 |
3001~
3050
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「第一三共」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
第一三共 | 376,400円 | +6.0% | +4.0% | 2.07% | 23.37倍 | 4.32倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
中外薬 | 756,000円 | +1.7% | +5.0% | 3.31% | 30.35倍 | 6.54倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
武 田 | 416,500円 | -1.1% | +75.3% | 4.80% | 28.53倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 665,000円 | +2.2% | +10.2% | 1.80% | 12.77倍 | 1.28倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 139,300円 | +0.9% | +380.2% | 5.60% | 19.18倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム